3 domain), which mediates the activation of NF-B and MAP kinases. The IL-1R/TLR superfamily can be divided into two subgroups based on the extracellular domain: the Ig domain-containing receptors (1) and the lecuine-rich repeat motif-containing receptors (2) . The Ig domain subgroup includes IL-1R, IL-18R, ST2, and single Ig IL-1R-related molecule (SIGIRR), whereas the lecuine-rich repeat motif-containing subgroup consists of a least 11 human TLRs (2-7). The IL-1R/TLR-mediated inflammatory response is critical for innate immunity and host defense against infections, whereas uncontrolled inflammation is detrimental to the host, leading to chronic inflammatory diseases. Thus, IL-1R/TLRmediated innate immunity must have regulatory mechanisms to limit the production of harmful toxins, resulting in resolution of the inflammatory diseases. SIGIRR (also referred to as TIR8) has been identified as a negative regulator for IL-1R, TLR4, and TLR9 signaling (8 -10) . SIGIRR is involved in colonic epithelial homeostasis, inflammation, and tumorigenesis through its impact on IL-1R/ TLR signaling (11, 12) . Recent studies have also demonstrated the critical role of SIGIRR in modulation of autoimmunity and inflammatory responses associated with infections (13, 14) . Therefore, it is important to identify additional IL-1R/TLRs that are inhibited by SIGIRR and determine the physiological consequences of this inhibition.
IL-33, a newly identified member of the IL-1 family (15) , has been implicated in the initiation and propagation of the Th2 immune response. Like IL-1 and IL-18 (members of the IL-1 family), IL-33 is produced as pro-IL-33 that is proteolytically cleaved by caspase 1 to generate mature IL-33. Mature rIL-33 has been shown to induce Th2 immunity, increase Th2 cytokines IL-4, IL-5, and IL-13, splenomegaly, eosinophilia, and pathological changes in mucosal tissues (15) . Recently, IL-33 has also been described as a chemoattractant for Th2 cells (16) . IL-33 mediates its function through its interaction with receptor complex consisting of ST2 molecule and IL-1R accessory protein, leading to NF-B and MAP kinase activation (15, 17) . Importantly, ST2, a member of the IL-1R family member (18, 19) , is specifically expressed in Th2 cells (20, 21) , but not Th1 cells, and has been reported to play a critical role in Th2 immunity (22, 23) .
Allergic asthma, a chronic inflammatory condition of the lung, is associated with prevailing CD4 ϩ T cell infiltrate in the airways, bronchial hyperreactivity, pulmonary eosinophilia, hyperplasia of smooth muscle, and elevated serum IgE concentration (24 -26) . CD4
ϩ Th cells are essential regulators in chronic allergic diseases. Upon activation, Th cells undergo differentiation into functionally distinct effector subsets (27) (28) (29) . Th1 cells produce IFN-␥ and regulate cellular immunity (30) , Th17 cells produce IL-17 and are implicated in autoimmune diseases (31), whereas Th2 cells play an essential role in orchestrating the inflammatory response associated with allergy and humoral immunity (32) . Th2 cells function through the production of Th2 cytokines (IL-4, IL-5, IL-9, and IL-13) to mediate Ag-induced allergic airway inflammation, especially eosinophilia, mucus production, and airways remodeling (33, 34) .
In this study, we report that SIGIRR negatively regulates IL-33/ST2 signaling in vitro (cell culture model) and in vivo (i.p. injection of IL-33). Importantly, SIGIRR-deficient mice developed stronger Th2 immune response in OVA-challenged asthma model compared with wild-type (WT) mice. Consistent with this finding, SIGIRR-deficient Th2 cells (polarized in vitro) produced higher levels of Th2-associated cytokines (including IL-4, IL-5, and IL-13) than that in WT cells. These results demonstrate a critical role of SIGIRR in Th2 cell function and the ability of SIGIRR to suppress Th2 immune response, possibly through its impact on IL-33-ST2-mediated signaling.
Materials and Methods

Stable and transient transfection
HEK293 cells were stably transfected with human ST2 (hST2)-puro vector using Fugene-6 reagent (Roche), according to the manufacturer's instruction, and after selection with puromycin (1 g/ml) either stably transfected with human SIGIRR (hSIGIRR) vector together with hygromycin selection vector and selected with hygromycin B (150 g/ml) or transiently transfected with full-length hSIGIRR, ⌬N, ⌬TIR, and ⌬C mutants.
Reporter assays
A total of 2 ϫ 10 5 cells was transfected with the indicated expression vectors (0, 100, 250, or 500 ng) plus 100 ng of the endothelial cell leukocyte adhesion molecule-1 promoter-derived NF-B luciferase reporter plasmid, and 10 ng of ␤-galactosidase plasmid for normalization, with a 1:3 ratio of DNA:FuGENE 6. Transfection of empty vector was used to ensure all samples received equal amounts of DNA. At 48 h after transfection, cells were stimulated with cytokines for 6 h. Cells were lysed, and luciferase activity was assessed using Reporter Lysis Buffer and Luciferase Assay Reagent (Promega). All results reported represent duplicate experiments with at least three independent transfections.
Western blot
Cells stimulated as indicated were harvested, washed once with cold PBS, and lysed for 30 min at 4°C in 1% Triton X-100, 150 mM NaCl, and 1 mM PMSF. Cellular debris were removed by centrifugation at 10,000 ϫ g for 15 min. For immunoblotting, cell extracts were fractionated by SDS-PAGE and transferred to Immobilon-P transfer membranes (Millipore), using a wet transfer apparatus (Bio-Rad). Immunoblot analysis was performed, and the bands were visualized with HRP-coupled goat anti-rabbit, goat antimouse, or donkey anti-goat Ig as appropriate (Rockland), using the ECL Western blotting detection system (GE Healthcare). Protein levels were equilibrated with the Protein Assay Reagent (Bio-Rad).
Coimmunoprecipitation
For coimmunoprecipitations, cells were harvested, washed once with cold PBS, and lysed in a Nonidet P-40-containing buffer (0.5% Nonidet P-40, 20 mM HEPES (pH 7.4), 150 mM NaCl, 12.5 mM ␤-glycerophosphate, 1.5 mM MgCl 2 , 10 mM NaF, 2 mM DTT, 1 mM Na 3 VO 4 , 2 mM EGTA, 20 M aprotinin, and 1 mM PMSF). Cell extracts were incubated with 1 g of Ab (anti-flag M2) or normal IgG (negative control) for 2 h, followed by incubation for 2 h with 30 l of protein G-Sepharose beads (prewashed and resuspended in lysis buffer at a 1:1 ratio). After incubations, the beads were washed four times with lysis buffer, separated by SDS-PAGE, and analyzed by immunoblotting.
Th1 and Th2 polarization
CD4-positive T cells were isolated from lymph nodes by negative depletion from SIGIRR WT and knockout mice. Single-cell suspension was incubated with FITC-conjugated anti-CD8 (53-6.7), anti-B220 (RA3-6B2), anti-NK1.1 (PK136), anti-heat-stable Ag (M1/69), anti-I-Ak/I-Ab (11-5.2 or AF6-120.1), and anti-CD16 (24G2) mAb, followed by anti-FITC microbeads. All Abs were purchased from BD Pharmingen. Magnetic separation was performed using LS magnetic column (Miltenyi Biotec). Negative fraction was collected. Purity of the CD4 T cells was usually greater than 95%. A total of 10 6 naive CD4 T cells was cultured in the presence of plate-bound anti-CD3/CD28 (3 g/ml each) and different combinations of Abs and cytokines for 4 days: for Th1 conditions (polarization), anti-IL-4 (11B11, 10 g/ml) plus IL-12 (10 ng/ml); for Th2 conditions (polarization), anti-IFN-␥ (XMG1.2, 10 g/ml), anti-IL-12 (C17.8, 10 g/ml), plus IL-4 (1000 U/ml) (44) . After incubation with IL-2 (10 U/ml) for additional 2 days (resting), 10 6 cells were restimulated with plate-bound anti-CD3/ CD28 (restimulation) with or without IL-33 (20 ng/ml). After 48 h, supernatants were collected and monitored for cytokines. For real-time PCR analysis, RNA was isolated from WT ex vivo polarized Th2 cells, and ST2, SIGIRR, and IL-33 gene expression was checked at different time points.
ELISA IL-4, IL-5, IL-13, and IFN-␥ production was measured using DuoSet ELISA Development Systems obtained from R&D Systems, following manufacturer's instruction.
Mice and in vivo IL-33 treatment
SIGIRR WT and knockout C57BL/6 mice were given i.p. PBS or 0.4 g of IL-33 protein daily for 7 days.
Blood analyses
Blood was collected via cardiac puncture.
Allergen sensitization protocol
C57BL/6 and BALB/c mice were immunized with 100 l of i.p. injection containing 10 g of OVA (chicken OVA, grade V; Sigma-Aldrich) and 20 mg of aluminum hydroxide (Sigma-Aldrich) on day 1 (BALB/c) or on days 1 and 8 (C57BL/6). Mice were challenged on days 14 -21 by exposure to ϳ40 min of 1% OVA aerosol diluted in PBS. This was accomplished by placing mice in a 30 ϫ 60-cm acrylic box ventilated by NOUVAG Ultrasonic 2000 nebulizer (NOUVAG USA). Mice were sacrificed and processed on day 22, 24 h after last aerosol challenge.
Bronchoalveolar lavage
The animals were anesthetized with pentobarbital. After placement of a tracheostomy tube, bronchoalveolar lavage (BAL) was performed by instilling 700 l of PBS and then withdrawing the fluid with gentle suction via the syringe. The typical BAL fluid return was 300 -400 l. White blood cells were counted on a hemocytometer, whereas cytologic examination was performed on cytospin preparations stained using Hema3 (Fisher Scientific). Differential counts were based on counts of 100 cells using standard morphologic criteria to classify the cells as eosinophils, lymphocytes, or other mononuclear leukocytes (alveolar macrophages and monocytes). Counts were performed by a single observer who was blinded to the study group.
Histologic analyses
Microscopic examination of mouse tissues was performed on histochoicefixed tissue section either stained with H&E or immunostained with antiLy-G6 FITC-conjugated Ab.
Quantitative real-time PCR
Total RNA was isolated using TRIzol reagent (Invitrogen), according to the manufacturer's instruction. A total of 3 g of total RNA was then used for the reverse-transcription reaction using Super Script II-reverse transcriptase (Invitrogen). Quantitative real-time PCR was performed in AB 7300 Real Time PCR System, and the gene expression was examined by SYBR Green PCR Master Mix (Applied Biosystems). PCR amplification was performed in triplicate, and water was used to replace cDNA in each run as a negative control. The reaction protocol included preincubation at 95°C to activate FastStart DNA polymerase for 10 min, amplification of 40 cycles that was set for 15 s at 95°C, and the annealing for 60 s at 60°C. The results were normalized with the housekeeping gene mouse ␤-actin. The specific primer sequences used in reaction are listed as follows: mouse ␤-actin, 5Ј-GGTCATCACTATTGGCAACG-3Ј and 5Ј-ACGGATGTCA ACGTCACACT-3Ј; mouse IL-5, 5Ј-CTCACCGAGCTCTGTTGACA AG-3Ј and 5Ј-CCAATGCATAGCTGGTGATTTTTAT-3Ј; mouse IL-4, 5Ј-CTCATGGAGCTGCAGAGACTCTT-3Ј and 5Ј-CATTCATGGTGC AGCTTATCGA-3Ј; mouse IL-13, 5Ј-TGACCAACATCTCCAATTGC A-3Ј and 5Ј-TTGTTATAAAGTGGGCTACTTCGATTT-3Ј; mouse IFN-␥-inducible protein-10 (IP-10), 5Ј-GACGGTCCGCTGCAAC TG-3Ј and 5Ј-GCTTCCCTATGGCCCTCATT-3Ј; KC, 5Ј-TAGGGTGA GGACATGTGTGG-3Ј and 5Ј-AAATGTCCAAGGGAAGCGT-3Ј; mouse IFN-␥, 5Ј-TGATGGCCTGATTGTCTTTCAA-3Ј and 5Ј-GGAT ATCTGGAGGAACTGGCAA-3Ј; mouse ST2L, 5Ј-GCCCTCATCCAG AACAACTC-3Ј and 5Ј-TCTTCCCTCCACTTGATGGT-3Ј; mouse IL-33, 5Ј-GGGAAGAAGGTGATGGTGAA-3Ј and 5Ј-CCGAAGGACTTT TTGTGAAGG-3Ј; and mouse SIGIRR, 5Ј-CTCCGTGACTCCTTCCTC TG-3Ј and 5Ј-TGGGATCTTTGTCATCCTGA-3Ј.
ELISPOT
For ELISPOT analyses, single-cell suspensions were prepared from the spleens and plated (100 or 500 ϫ 10 3 /100 l) in 96-well ImmunoSpot M200 plates (Cellular Technology) previously coated with capture Abs for IL-5 (TRFK5; eBioscience) or IFN-␥ (R4-6A2; eBioscience) (100 l/well in PBS overnight at 4°C), blocked with PBS-1% BSA (Sigma-Aldrich), and washed three times with PBS. Syngeneic APCs, prepared by treating adherent splenocytes with mitomycin C (50 g/ml; 20 min at 37°C), were used at 2 ϫ 10 5 APCs/100 l. Ag-specific responses were elicited by the addition of OVA323-339 (Research Genetics) at a final concentration of 4 g/ml. After incubation (1 day at 37°C), the plates were washed, and biotinylated detection Abs for IL-5 (TRFK4; eBioscience) or IFN-␥ (XMG1.2; eBioscience) in PBS-Tween 20 1% BSA were added to the wells for 2 h, followed by washing and incubation 2 h with streptavidinalkaline phosphatase (DakoCytomation). Spots were developed with a NBT chloride (Bio-Rad) and 5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich) mixture, visualized, and counted on an ImmunoSpot Series 1 Analyzer (Cellular Technology).
Statistical analysis
The data are presented as mean plus SD. The significance of differences between two groups was determined by Student's t test.
Results
SIGIRR inhibits IL-33-ST2-mediated signaling
ST2, a member of the IL-1R family, has recently been identified as the receptor for IL-33. IL-33 stimulation induced phosphorylation of ERK, JNK, p38, and IB␣ in human 293 cells transfected with hST2 expression construct (hST2-293 cells). SIGIRR has been shown to function as a negative regulator for signaling pathways mediated by some members of the IL-1R-TLR superfamily (9, 10). We therefore examined whether SIGIRR has the ability to modulate IL-33-ST2-mediated signaling. Interestingly, expression of SIGIRR effectively inhibited IL-33-induced ERK, JNK, and IB phosphorylation in hST2-293 cells, whereas IL-33-induced p38 phosphorylation was moderately suppressed in the same transfected cells (Fig.  1A) . Furthermore, IL-33-induced NF-B-dependent luciferase activity was much reduced in hST2-293 cells transfected with SIGIRR compared with that transfected with vector control, indicating the inhibitory effect of SIGIRR on IL-33-induced NF-B activation (Fig. 1B) . 
The TIR domain and Ig domain of SIGIRR are sufficient to inhibit ST2 signaling
We investigated whether SIGIRR exerts the inhibitory effect on IL-33 signaling through its interaction with ST2 molecule upon stimulation. Cell lysates from untreated or IL-33-treated hST2-293 cells transfected with flag-tagged SIGIRR were immunoprecipitated with anti-flag (M2), followed by Western analyses with antiflag and anti-hST2 Abs. As shown in Fig. 1C , SIGIRR indeed formed a complex with ST2 upon IL-33 stimulation, suggesting that SIGIRR inhibits IL-33-mediated signaling through its interaction with the receptor complex.
SIGIRR deletion mutants were used to determine the domain(s) of SIGIRR required for its interaction with ST2. Although deletion of C-terminal tail (⌬C) did not have any impact on the ability of SIGIRR to interact with ST2, ⌬TIR had slightly reduced interaction with ST2 compared with full-length SIGIRR upon IL-33 stimulation (Fig. 1C) . Although Ig domain deletion mutant (⌬N) was expressed at lower level (compared with ⌬TIR or ⌬C), it was still able to form a complex with ST2 upon IL-33 stimulation (Fig. 1C) . The SIGIRR deletion mutants were then examined for their ability to inhibit IL-33-ST2 signaling. Although ⌬C and ⌬N can inhibit IL-33-ST2 signaling as efficiently as the full-length SIGIRR, ⌬TIR can partially inhibit (Fig. 1B) . Taken together, these results suggest that whereas both the extracellular Ig and the intracellular TIR domain of SIGIRR are able to interact with ST2, the TIR domain is more critical in inhibiting IL-33 signaling than the Ig domain.
SIGIRR deficiency leads to increased production of type 2 cytokines in Th2 cells
Previous studies have shown that ST2 is strongly expressed on Th2, but not Th1 cells (20, 21) . Because SIGIRR exerts inhibitory effect on ST2 signaling, it is important to determine whether SI-GIRR is coexpressed with ST2. To examine SIGIRR expression in T cell subsets, naive CD4-positive T cells were isolated from WT and SIGIRR-deficient mice and polarized in vitro into Th1 and Th2 cells, followed by Western analysis with anti-SIGIRR Ab. As shown in Fig. 2A , SIGIRR was expressed at a higher level in Th2 cells than that in Th1 cells, indicating a possible functional role of SIGIRR in this T cell subset. Importantly, Th2 cytokines (IL-4, IL-5, and IL-13) were indeed significantly increased in SIGIRRdeficient Th2 cells compared with that in WT Th2 cells during restimulation, indicating a negative regulatory role of SIGIRR in Th2 cell function (Fig. 2B) . Interestingly, whereas ST2 expression was induced on day 1 of polarization, SIGIRR expression was induced on day 3 of polarization and during restimulation, suggesting that SIGIRR might serve as a negative feedback control in Th2 cell polarization and restimulation (Fig. 2C) . It is intriguing that IL-33 expression was highly induced during restimulation, suggesting that the increased Th2 cytokine production in SIGIRRdeficient Th2 cells might be due to the action of endogenous IL-33 (Fig. 2C) . Whereas IL-33 treatment only slightly induced IL-13, but not IL-4 or IL-5 (statistically not significant) in Th2 cells from WT mice, Th2 cytokines (IL-5, IL-13, and IL-4) were moderately and significantly elevated in SIGIRR-deficient Th2 cells upon IL-33 stimulation (Fig. 2B) , suggesting the potential role of SI-GIRR in modulating IL-33-ST2 signaling in Th2 cells. Taken together, these results implicate the potential role of SIGIRR in the regulation of Th2 immune response, possibly via inhibition of IL-33-ST2 signaling in Th2 cells. Future studies are required to understand the detailed mechanism by which SIGIRR modulates IL-33-ST2 signaling in Th2 cells.
SIGIRR deficiency increases IL-33-dependent Th2 immune response
Previous studies reported that i.p. injection of rIL-33 was able to induce Th2 immunity, including production of Th2 cytokines (IL-4, IL-5, and IL-13), splenomegaly, eosinophilia, and inflammatory responses in the lung, indicating the critical role of IL-33 FIGURE 4. SIGIRR deficiency leads to hyperallergic pulmonary inflammation in C57BL/6 mice. A, Total BAL and differential cell count were analyzed in samples from control or OVA-sensitized and challenged (daily aerosol challenge with OVA for 7 days) WT (n ϭ 9) and SIGIRR-deficient mice (n ϭ 6); ‫,ء‬ p Ͻ 0.05 vs SIGIRR WT; #, p Ͻ 0.05 vs SIGIRR WT control. B, Cytospins prepared from the BAL from control or OVAsensitized and challenged WT and SI-GIRR-deficient mice were stained with Hema3, and differential cell counting was performed using standard morphological criteria. Magnification ϫ400.
in mediating Th2-associated immune responses (15) . To examine the role of SIGIRR in IL-33-ST2 signaling in vivo, WT and SIGIRR-deficient mice were treated with rIL-33 through i.p. injections. As shown in Fig. 3A , IL-33 stimulation induced significantly higher levels of IL-5 and IL-13 in the serum of SI-GIRR-deficient mice compared with that in WT mice. Furthermore, SIGIRR-deficient mice displayed more severe splenomegaly in response to IL-33 stimulation than the WT control mice (Fig. 3B) . Consistent with this, IL-33 treatment resulted in greater numbers of BAL cells in SIGIRR-deficient mice compared with that in WT mice (Fig. 3C ). More severe inflammation was observed in lungs of SIGIRR-deficient mice injected with IL-33 than that in WT mice (Fig. 3D) . Taken together, these results demonstrated that SIGIRR-deficient mice were hyperresponsive to IL-33, indicating a negative regulatory role of SIGIRR for IL-33-ST2-mediated Th2 immunity.
SIGIRR deficiency leads to hyperallergic pulmonary inflammation
It is well known that Ag-induced allergic pulmonary inflammation is mediated by Th2 cells and their cytokines (IL-4, IL-5, and IL-13). We then examined the role of SIGIRR in allergic pulmonary inflammation. Female C57BL/6 or BALB/c SIGIRR-deficient mice (n ϭ 9 for C57BL/6; n ϭ 6 for BALB/c) and their WT littermates (n ϭ 6 for each background) were subjected to an OVA-induced model of asthma. OVA/alum-sensitized WT and SI-GIRR-deficient mice (on C57BL/6 or BALB/c background) were then challenged seven times with aerosolized OVA. Twenty-four hours after last challenge, the mice were analyzed for BAL cells and lung inflammation. Eosinophils and lymphocyte counts were increased in both C57BL/6 and BALB/c SIGIRR-deficient mice compared with that in their WT control mice (Fig. 4 and see   FIGURE 5 . SIGIRR deficiency leads to hyperallergic pulmonary inflammation in C57BL/6 mice. A, The lung sections from control or OVA-sensitized and challenged WT and SIGIRR-deficient mice (as described in Fig. 4) were stained with H&E. Magnification ϫ100. B and C, Lung sections from control and OVA-sensitized and challenged WT and SIGIRR-deficient mice were stained with anti-Ly-6G; ‫,ء‬ p Ͻ 0.005 vs SIGIRR WT; #, p Ͻ 0.05 vs SIGIRR WT control. Magnification ϫ100. D, Total RNA from lung tissues from control or OVA-sensitized and challenged WT and SIGIRR-deficient mice was subjected to real-time PCR analysis for the levels of IL-4, IL-5, IL-13, IFN-␥, KC, and IP-10 mRNA. ‫,ء‬ p Ͻ 0.05 vs SIGIRR WT; #, p Ͻ 0.05 vs SIGIRR WT control. Fig. 6A ). Histological analysis of lung tissue showed that SIGIRR deficiency leads to enhanced lung inflammation (Figs. 5A and 6B ). Lung and airway recruitment of granulocytes, predominantly eosinophils and neutrophils, were increased in both C57BL/6 and BALB/c SIGIRR-deficient mice compared with their WT mice (Figs. 5, A-C, and 6B) . The increased asthma phenotype in the C57BL/6 or BALB/c SIGIRR-deficient mice correlated with increased expression of Th2 cytokines (IL-4 and IL-5) and chemokines (including KC and IP-10) in the lung tissues (Figs. 5D and  6C ). Th2 cytokine IL-13 was only significantly increased in BALB/c, but not in C57BL/6 SIGIRR-deficient lung tissues compared with WT control mice (Figs. 5D and 6C) .
Considering the regulatory role of SIGIRR in the production of Th2 cytokines in polarized Th2 cells, we suspect SIGIRR deficiency impacts on the activation of OVA-specific T cells polarized in vivo, leading to hyperallergic pulmonary inflammation. We examined responses of SIGIRR-deficient and WT splenocytes 14 days after OVA immunization (on C57BL/6 or BALB/c background). Splenocytes from SIGIRR-deficient mice showed increased frequencies of T cells secreting IL-5, but not IFN-␥, indicating enhanced frequencies of Th2 lineage-derived T cells, a finding consistent with enhanced Th2 immune responsiveness in SIGIRR-deficient mice (Fig. 7, A and C) . The induction of pulmonary inflammation in the mouse model of asthma requires the induction of both cellular as well as humoral immunity. Therefore, we also examined the induction of OVA-specific Ab in WT and SIGIRR-deficient animals after OVA sensitization. SIGIRR-deficient mice demonstrated increased induction of OVA-specific IgE compared with WT mice (Fig. 7, B and D) . Collectively, SIGIRR deficiency enhanced in vivo Th2 humoral and cellular responses in a murine model of allergic asthma.
Discussion
Although the previous studies reported the role of SIGIRR/TIR8 in mucosal immunity (8, 12) , recent studies have indicated the critical role of SIGIRR/TIR8 in modulation of autoimmunity and inflammatory responses associated with infections (13, 14) . It is clear that SIGIRR/TIR8 is an important modulator for inflammatory and immune responses. In this study, we report the regulatory role of SIGIRR in adaptive immunity through its impact on Th2 cell function and Ag-induced allergic pulmonary inflammation, providing new opportunity for therapeutic strategies of asthma and other Th2-mediated allergic inflammatory responses.
Recent studies have demonstrated that IL-33 is the ligand for ST2, a member of the IL-1R family, which is specifically expressed in Th2 cells, but not Th1 cells. IL-33 has been shown to mediate its biological activities via ST2, activating NF-B and MAP kinases and driving production of Th2-associated cytokines from polarized Th2 cells. IL-33 injected i.p. resulted in splenomegaly, eosinophilia, elevated serum IgE levels, and inflammatory responses in the lung and the gut, indicating the critical role of IL-33 in mediating Th2-associated immune responses.
SIGIRR, a negative regulator of IL-1R/TLR signaling, is also specifically expressed in Th2 cells, but not Th1 cells. In this study, we show that SIGIRR effectively inhibited IL-33-induced ERK, JNK, p38, and IB phosphorylation in hST2-293 cells. Furthermore, SIGIRR formed a complex with ST2 receptor upon IL-33 stimulation, suggesting that SIGIRR probably inhibits IL-33-mediated signaling through its interaction with the receptor complex. We have previously reported that whereas both the extracellular Ig domain and the intracellular TIR domains are important for SI-GIRR to inhibit IL-1 signaling, only the TIR domain is necessary for SIGIRR to inhibit LPS signaling. We now find that both the extracellular Ig domain and the intracellular TIR are able to inhibit IL-33 signaling probably through interaction with the extracellular Ig domain and intracellular TIR of ST2, respectively.
Consistent with the high expression of SIGIRR in Th2 cells, SIGIRR deficiency leads to elevated Th2 cytokine production in Th2 cells polarized in vitro (20, 21) . Furthermore, Ag-induced Th2-mediated allergic pulmonary inflammation was significantly enhanced in SIGIRR-deficient mice, indicating the critical role of SIGIRR in modulating Th2 response. Several lines of evidence suggest that IL-33 signaling might play a role in SIGIRR-modulated Th2 response. First, SIGIRR interacts with ST2 and inhibits IL-33-ST2 signaling in cell culture model. Second, IL-33-induced Th2 response (via IL-33 i.p. injection) was significantly enhanced in SIGIRR-deficient mice, indicating the inhibitory role of SIGIRR in IL-33 signaling in vivo. Third, IL-33 stimulation induced higher Th2 cytokines in SIGIRR-deficient Th2 cells than that in WT Th2 cells. It is intriguing that IL-33 expression was highly induced during Th2 polarization and restimulation, suggesting that the increased Th2 cytokine production in SIGIRR-deficient Th2 cells (without exogenous IL-33 treatment) might be due to the action of endogenous IL-33. Although our data showed that exogenous IL-33 induced significantly higher levels of Th2 cytokines in SI-GIRR-deficient Th2 cells compared with WT Th2 cells, the relative low impact of exogenous IL-33 might be due to the presence of endogenous IL-33. Taken together, these results implicate the potential role of IL-33-ST2 signaling in SIGIRR-regulated Th2 cell function and Th2 immune response. Interestingly, we found that whereas ST2 expression was induced on day 1 of polarization, SIGIRR expression was induced on day 3 of polarization and during restimulation, suggesting the potential role of SIGIRR to serve as a negative feedback control. Future studies are required to understand the precise function of SIGIRR-modulated ST2 signaling in Th2 cell function.
Previous studies showed that a neutralizing Ab against T1/ST2 or a T1/ST2-Ig fusion protein inhibited Th2 cell differentiation and Th2 effector functions in vivo, including allergic airway inflammation (20, 22, 23, 35) . Although a decrease in IL-5 production and recruitment of eosinophils to the lung were observed in Nippostrongylus brasiliensis-infected ST2-deficient mice as compared with WT mice, absence of ST2 in mice also led to a significant defect in the OVA-induced macrophage recruitment to the lung. However, some studies using ST2-deficient mice suggested that ST2 is not essential for Th2 response, suggesting a compensatory mechanism(s) in the absence of ST2 (36 -38) . The fact that SI-GIRR deficiency led to a hyper-Th2 response in the OVA-challenged asthma model indicates the essential role of SIGIRR in modulating Th2 immunity. Therefore, it is plausible that whereas IL-33-ST2-mediated Th2 immunity can be compensated by other pathway(s) in the genetically altered mice, IL-33-ST2 signaling has to be appropriately modulated through the action of regulatory molecules such as SIGIRR. Loss of such modulation (i.e., SIGIRR deficiency) leads to dysregulation of Th2 immunity, resulting in hyper-Th2 immune responses and increased allergic inflammatory responses.
Although ST2 is expressed in Th2, but not Th1 cells (20, 21, 39, 40) , ST2 is also expressed in other immune cells, including mast cell, macrophages (41) , and NKT cells (42) . Recent study showed that IL-33 can promote a variety of effector responses through ST2 on human basophils, invariant NKT, and NK cells (43). Schmitz Hyperactivation of Th2 cells and high IgE production in SIGIRR-deficient mice after OVA/Alum priming (on C57BL/6 or BALB/c background). WT and SIGIRR-deficient mice (C57BL/6, n ϭ 6 (A) or BALB/c, n ϭ 3 (C)) were immunized with OVA/Alum by i.p. injection. Fourteen days after immunization, the spleens were harvested, and IL-5 and IFN-␥ production was measured by ELISPOT. ‫,ء‬ p Ͻ 0.05 vs SIGIRR WT. Serum from control or OVA-sensitized WT and SIGIRR-deficient mice (C57BL/6, n ϭ 6 (B) or BALB/c, n ϭ 3 (D)) was subjected to ELISA analysis for OVA-specific IgE production. ‫,ء‬ p Ͻ 0.05 vs SIGIRR WT; #, p Ͻ 0.05 vs SIGIRR WT control. et al. (15) reported that IL-33 is able to mediate induction of Th2 cytokines and Th2-associated inflammatory response in the absence of Ag-dependent response. It is possible that cell types other than Th2 cells are involved in IL-33-induced Th2 response in vivo, including mast cells, NKT, and basophiles. Therefore, the impact of SIGIRR on Ag-induced allergic pulmonary inflammation might not only be due to its regulatory role in Th2 cell function. Other IL-33-responsive cell types and additional pathways (other than IL-33-ST2) might contribute to SIGIRR-modulated Th2 immune responses.
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